The Corpuscles of Stannius, Calcium-Sensing Receptor, and Stanniocalcin: Responses to Calcimimetics and Physiological ChallengesGREENWOOD, Michael P; FLIK, Gert; WAGNER, Graham F et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 7, pp 3002-3010, issn 0013-7227, 9 p.Article

The new role of calcimimetics as vasculotropic agentsAL-ALY, Ziyad.Kidney international. 2009, Vol 75, Num 1, pp 9-12, issn 0085-2538, 4 p.Article

Le récepteur sensible au calcium : physiologie et pathologie = Calcium sensing receptor : physiology and pathologyFAIVRE-DEFRANCE, F; MARCELLI-TOURVIEILLE, S; ODOU, M.-F et al.Annales d'endocrinologie. 2006, Vol 67, Num 1, pp 45-53, issn 0003-4266, 9 p.Article

Calcimimetics and calcilytics- : fooling the calcium receptorSTEDDON, Simon J; CUNNINGHAM, John.Lancet (British edition). 2005, Vol 365, Num 9478, pp 2237-2239, issn 0140-6736, 3 p.Article

No effect of renal function or dialysis on pharmacokinetics of cinacalcet (Sensipar®/Mimpara®)PADHI, Desmond; HARRIS, Robert Z; SALFI, Margaret et al.Clinical pharmacokinetics. 2005, Vol 44, Num 5, pp 509-516, issn 0312-5963, 8 p.Article

Metabolism and disposition of calcimimetic agent cinacalcet HCL in humans and animal modelsKUMAR, Gondi N; SPROUL, Christopher; POPPE, Leszek et al.Drug metabolism and disposition. 2004, Vol 32, Num 12, pp 1491-1500, issn 0090-9556, 10 p.Article

L'étude ADVANCE en questions = Questions about the ADVANCE studyJEAN, Guillaume; CHAZOT, Charles.Néphrologie & thérapeutique. 2012, Vol 8, Num 3, pp 131-134, issn 1769-7255, 4 p.Article

Calcimimetic Inhibits Late-Stage Cyst Growth in ADPKDGATTONE, Vincent H; CHEN, Neal X; SINDERS, Rachel M et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 7, pp 1527-1532, issn 1046-6673, 6 p.Article

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidismPEACOCK, Munro; BILEZIKIAN, John P; KLASSEN, Preston S et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 1, pp 135-141, issn 0021-972X, 7 p.Article

Comparison of Active Vitamin D Compounds and a Calcimimetic in Mineral HomeostasisNGUYEN-YAMAMOTO, Loan; BOLIVAR, Isabel; STRUGNELL, Stephen A et al.Journal of the American Society of Nephrology. 2010, Vol 21, Num 10, pp 1713-1723, issn 1046-6673, 11 p.Article

Calcimimetics in chronic kidney disease : evidence, opportunities and challengesEVENEPOEL, Pieter.Kidney international. 2008, Vol 74, Num 3, pp 265-275, issn 0085-2538, 11 p.Article

Les formes cliniques et biologiques de l'hyperparathyroïdie secondaire en dialyse = Clinical and biological forms of secondary hyperparathyroidism in dialysis patientsJEAN, Guillaume; SOUBERBIELLE, Jean-Claude; LORRIAUX, Christie et al.Néphrologie & thérapeutique. 2012, Vol 8, Num 1, pp 35-40, issn 1769-7255, 6 p.Article

Hyperparathyroïdie secondaire et anémie. Effets d'un calcimimétique sur le contrôle de l'anémie des hémodialysés chroniques. Étude pilote = Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot StudyMPIO, Ignace; BOUMENDJEL, Nourredine; ATTAF, David et al.Néphrologie & thérapeutique. 2011, Vol 7, Num 4, pp 229-236, issn 1769-7255, 8 p.Article

Effets osseux et extra-osseux de l'hyperparathyroïdie persistante après transplantation pénale et prise en charge : OS ET METABOLISME EN TRANSPLANTATION RENALE = Consequences and management of persisting secondary hyperparthyroidism after renal transplantationGUITARD, J; COURBEBAISSE, M; MILIOTO, O et al.Le Courrier de la transplantation. 2011, Vol 11, Num 3, issn 1628-8319, 122-132 [9 p.]Article

Traitement de l'hyperparathyroïdie secondaire, résistante aux thérapeutiques conventionnelles, et de l'hyperparathyroïdie tertiaire par le cinacalcet: une stratégie efficace = Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: An efficiency strategyJEAN, Guillaume; VANEL, Thierry; TERRAT, Jean-Claude et al.Néphrologie & thérapeutique. 2010, Vol 6, Num 2, pp 105-110, issn 1769-7255, 6 p.Article

Hyperparathyroïdie primaire: nouveaux concepts, nouvelles recommandations = Primary hyperparathyroidism: new concepts, new recommendationsCROUZEIX, G; KERLAN, V.Annales d'endocrinologie. 2014, Vol 75, issn 0003-4266, S21-S36, SUP1Conference Paper

The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE TrialPARFREY, Patrick S; CHERTOW, Glenn M; WHEELER, David C et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 12, pp 4834-4844, issn 0021-972X, 11 p.Article

Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcetYOKOYAMA, Keitaro; OHKIDO, Ichiro; IWAMOTO, Takeo et al.Clinical nephrology. 2012, Vol 78, Num 1, pp 85-86, issn 0301-0430, 2 p.Article

Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trialCHERTOW, Glenn M; CORREA-ROTTER, Ricardo; MIX, Thomas-Christian et al.Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 7, pp 2872-2879, issn 0931-0509, 8 p.Article

Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO (evaluation of cinacalcet HCl outcome) studyYOKOYAMA, Keitaro; OHKIDO, Ichiro; ISHIDA, Mari et al.Clinical nephrology. 2012, Vol 78, Num 2, pp 87-92, issn 0301-0430, 6 p.Article

Hyperparathyroidism in chronic kidney disease: complexities within the commonplaceCAI, Michael M; MCMAHON, Lawrence P; SMITH, Edward R et al.Clinical medicine. 2012, Vol 12, Num 4, pp 333-337, issn 1470-2118, 5 p.Article

Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational studyEVENEPOEL, Pieter; SPRANGERS, Ben; LERUT, Evelyne et al.Clinical transplantation. 2012, Vol 26, Num 3, pp 393-402, issn 0902-0063, 10 p.Article

Pharmacokinetic and Pharmacodynamic Properties of the Calcimimetic Agent Cinacalcet (KRN1493) in Healthy Male Korean Subjects: A Randomized, Open-Label, Single Ascending-Dose, Parallel-Group StudySEUNGHWAN LEE; NAMYI GU; KIM, Bo-Hyung et al.Clinical therapeutics. 2012, Vol 34, Num 5, pp 1160-1169, issn 0149-2918, 10 p.Article

Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidismJACOBS, L; SAMSON, M. M; VERHAAR, H. J. J et al.Netherlands journal of medicine. 2012, Vol 70, Num 1, pp 35-38, issn 0300-2977, 4 p.Article

Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing DialysisThe New England journal of medicine. 2012, Vol 367, Num 26, pp 2482-2494, issn 0028-4793, 13 p.Article